98 related articles for article (PubMed ID: 3228054)
21. Autoimmune liver diseases.
Manns MP; Nakamura RM
Clin Lab Med; 1988 Jun; 8(2):281-301. PubMed ID: 3284697
[TBL] [Abstract][Full Text] [Related]
22. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis.
Bernstein RM; Neuberger JM; Bunn CC; Callender ME; Hughes GR; Williams R
Clin Exp Immunol; 1984 Mar; 55(3):553-60. PubMed ID: 6368058
[TBL] [Abstract][Full Text] [Related]
23. Target platelet antigens of autoantibodies in patients with primary biliary cirrhosis.
Feistauer SM; Penner E; Mayr WR; Panzer S
Hepatology; 1997 Jun; 25(6):1343-5. PubMed ID: 9185750
[TBL] [Abstract][Full Text] [Related]
24. Prevalence of immune disturbances and chronic liver disease in family members of patients with primary biliary cirrhosis.
Bittencourt PL; Farias AQ; Abrantes-Lemos CP; Goncalves LL; Goncalves PL; Magalhães EP; Carrilho FJ; Laudanna AA; Cançado EL
J Gastroenterol Hepatol; 2004 Aug; 19(8):873-8. PubMed ID: 15242489
[TBL] [Abstract][Full Text] [Related]
25. Enhanced apoptosis relates to bile duct loss in primary biliary cirrhosis.
Harada K; Ozaki S; Gershwin ME; Nakanuma Y
Hepatology; 1997 Dec; 26(6):1399-405. PubMed ID: 9397977
[TBL] [Abstract][Full Text] [Related]
26. [Infiltrating T-cells in primary biliary cirrhosis recognize mitochondrial epitopes].
Löhr H; Fleischer B; Gerken G; Meyer zum Büschenfelde KH; Manns M
Z Gastroenterol; 1993 Feb; 31 Suppl 2():99-103. PubMed ID: 7483731
[TBL] [Abstract][Full Text] [Related]
27. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome.
Geubel AP; Baggenstoss AH; Summerskill WH
Gastroenterology; 1976 Sep; 71(3):444-9. PubMed ID: 950095
[TBL] [Abstract][Full Text] [Related]
28. Membranous expression of Lewis Y antigen in clustered hepatocytes in chronic viral, autoimmune, and alcoholic liver diseases but not in biliary diseases.
Sasaki M; Kono N; Nakanuma Y
Mod Pathol; 1994 Apr; 7(3):339-46. PubMed ID: 8058706
[TBL] [Abstract][Full Text] [Related]
29. Complement activation in chronic liver disease.
Munoz LE; De Villiers D; Markham D; Whaley K; Thomas HC
Clin Exp Immunol; 1982 Mar; 47(3):548-54. PubMed ID: 7083631
[TBL] [Abstract][Full Text] [Related]
30. [Quantitation of antigen specific T lymphocytes in peripheral blood of patients with primary biliary cirrhosis using tetramer technology].
Liu HY; Zhang J; Deng AM; Geng HL; Zhou L; Zhu Y; Xu DX; Zhong RQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2006 Jan; 22(1):78-81. PubMed ID: 16388752
[TBL] [Abstract][Full Text] [Related]
31. Serum secretory IgA, IgA1 and IgA2 subclasses in inflammatory bowel and chronic liver diseases.
Soppi E; Granfors K; Leino R
J Clin Lab Immunol; 1987 May; 23(1):15-7. PubMed ID: 3612757
[TBL] [Abstract][Full Text] [Related]
32. Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease.
Kurki P; Gripenberg M; Teppo AM; Salaspuro M
Liver; 1984 Apr; 4(2):134-8. PubMed ID: 6610088
[TBL] [Abstract][Full Text] [Related]
33. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study.
Sasaki M; Nakanuma Y
Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144
[TBL] [Abstract][Full Text] [Related]
34. The immune response to alkaline phosphatase and other immunogens in patients with primary biliary cirrhosis.
Harding G; McKenna R; Minuk G
Hepatogastroenterology; 2001; 48(37):66-70. PubMed ID: 11269001
[TBL] [Abstract][Full Text] [Related]
35. Studies on lymphocyte hyporesponsiveness in cirrhosis: the role of increased monocyte suppressor cell activity.
Holdstock G; Chastenay BF; Krawitt EL
Gastroenterology; 1982 Feb; 82(2):206-12. PubMed ID: 6459260
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis.
Nakamura M; Takii Y; Ito M; Komori A; Yokoyama T; Shimizu-Yoshida Y; Koyabu M; Matsuyama M; Mori T; Kamihira T; Daikoku M; Migita K; Yatsuhashi H; Nozaki N; Shimoda S; Ishibashi H
J Autoimmun; 2006 Mar; 26(2):138-45. PubMed ID: 16337775
[TBL] [Abstract][Full Text] [Related]
37. Lack of association between appendectomy and primary biliary cirrhosis.
Rigopoulou EI; Georgiadou SP; Barbanis S; Dalekos GN
Scand J Gastroenterol; 2006 May; 41(5):573-6. PubMed ID: 16638700
[TBL] [Abstract][Full Text] [Related]
38. Neutrophil function in chronic liver disease.
Campbell AC; Dronfield MW; Toghill PJ; Reeves WG
Clin Exp Immunol; 1981 Jul; 45(1):81-9. PubMed ID: 7030541
[TBL] [Abstract][Full Text] [Related]
39. Altered expression of TLR homolog RP105 on monocytes hypersensitive to LPS in patients with primary biliary cirrhosis.
Honda Y; Yamagiwa S; Matsuda Y; Takamura M; Ichida T; Aoyagi Y
J Hepatol; 2007 Sep; 47(3):404-11. PubMed ID: 17448566
[TBL] [Abstract][Full Text] [Related]
40. Decreased serum leptin levels in primary biliary cirrhosis: a link between metabolism and autoimmunity?
Rieger R; Oertelt S; Selmi C; Invernizzi P; Podda M; Gershwin ME
Ann N Y Acad Sci; 2005 Jun; 1051():211-7. PubMed ID: 16126961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
